Kidger: RN's Overlooked Highlights Are Regulatory, Toxicology and GMP

Patrick Kidger argued that the overlooked highlights of RN's announcement are its regulatory, toxicology and GMP manufacturing pathways rather than the AI itself, as the regulatory landscape shifts rapidly.

2026-10-21 ~ 2026-10-21 · 2 related posts